RecruitingNot ApplicableNCT06950203

The Effect of Supplementation With Fish Oil (EPAX EVOLVE 05) on Sperm Quality

A Randomised, Double Blinded Study to Determine the Effect of Supplementation With Fish Oil (EPAX EVOLVE 05) on Sperm Quality in Healthy Men.


Sponsor

Epax Norway AS

Enrollment

80 participants

Start Date

Mar 10, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The study will enrol men that have a poor sperm quality. They will take either a placebo or fish oil capsule (2 per day) for 3 months. At the beginning and end of the study the participant will be asked for a sperm sample for measuring quality parameters.


Eligibility

Sex: MALEMin Age: 18 YearsMax Age: 55 Years

Inclusion Criteria7

  • Men aged 18-55
  • Referred for or claiming a semen analysis.
  • Willing to have at least 2 days abstinence of sexual activity prior to a sperm sample being taken.
  • Reduced semen quality defined as:
  • • Progressive motility: \<30%
  • Willing to refrain from omega-3/cod liver oil supplementation during the study. Use of other supplements is allowed.
  • \-

Exclusion Criteria7

  • Known allergy to fish products
  • Historically, known, or suspected bacterial infection in reproductive organs
  • Varicocele suspected from physical examination
  • Azoospermia
  • Diagnosis of diabetes (type 2)
  • Diagnosis of Crohn´s Disease
  • Inferior semen quality due to medical reasons, such as cryptorchidism (via questionnaire/medical records) -

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTVery Long Chain Polyunsaturated Fatty Acids

Fish oil with DHA and VLCPUFA

DIETARY_SUPPLEMENTComparator arm (DHA)

Oil containing equal DHA content to active arm


Locations(1)

Medicus Group AS

Oslo, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06950203


Related Trials